Navigation Links
3SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results
Date:8/15/2011

expenses for the second quarter of 2011 were RMB65.3 million (US$10.1 million), or 48.0% of net revenues, compared to RMB48.0 million (US$7.1 million), or 45.5% of net revenues, for the same period in 2010. The increase is mainly attributable to expanded sales and marketing activities, including new product launch initiatives for TPIAO for ITP.
  • General and administrative expenses. General and administrative expenses for the second quarter of 2011 were RMB15.4 million (US$2.4 million), or 11.3% of net revenues, compared to RMB13.5 million (US$2.0 million), or 12.8% of net revenues for the same period in 2010.

  • Operating income. Operating income was RMB30.1 million (US$4.7 million) for the second quarter of 2011, a 7.7% increase from operating income of RMB27.9 million (US$4.1 million) for the same period in 2010. Operating margin for the second quarter of 2011 was 22.1%, a 4.4% decline from operating margin of 26.5% for the same period in 2010. The decline in operating margin is primarily due to increased depreciation expenses related to the new plant and increased R&D and sales, marketing and distribution expenses.

    Interest income. Net interest income was RMB5.1 million (US$0.8 million) for the second quarter of 2011, compared to RMB2.7 million (US$0.4 million) for the same period in 2010. The increase is primarily due to the combined effect of increased time deposits and higher interest rates on time deposits.

    Net income. Net income was RMB30.4 million (US$4.7 million) for the second quarter of 2011, a 18.9% increase over net income of RMB25.5 million (US$3.8 million) for the same period in 2010. Net income per ADS on a fully-diluted basis for the second quarter of 2011 increased to RMB1.34 (US$0.21) compared to RMB1.16 (US$0.17) for the same period in 2010. Net margin for the second quarter of 2011 was 22.4%, a 1.8% decrease over net margin of 24.2% fo
    '/>"/>

    SOURCE 3SBio Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

    Related medicine technology :

    1. 3SBio Inc. Schedules Unaudited Second Quarter 2011 Results
    2. 3SBio Inc. Announces SFDA Approval of High-Dose EPIAO
    3. 3SBio Announces Conversion of Isotechnika Debenture
    4. 3SBio Inc. Schedules Third Quarter 2010 Unaudited Financial Results
    5. 3SBio Announces Partial Conversion of Isotechnika Debenture
    6. 3SBio Announces Investor Conference Schedule
    7. 3SBio and Isotechnika Pharma Announce Strategic Partnership to Develop and Commercialize Voclosporin in China
    8. 3SBio Inc. Announces Results of Annual General Meeting
    9. NewCardio Announces Financial Results for Its 2011 Second Quarter
    10. Dehaier Medical Announces Record Second Quarter 2011 Financial Results
    11. Emdeon Announces Support for Electronic Prescribing of Controlled Substances Using the DEA-Allowed Quicker-to-Market Approach
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/3/2015)... 2015  BioElectronics Corporation (OTC Pink: BIEL), maker of ... Andrew J. Whelan , President will be interviewed ... Business" at 9am EDT on Wednesday, August 5 th ... http://tunein.com/radio/Money-Matters-Boston-1120-s27548/ Mr. ... the company,s flagship product, ActiPatch Therapy, is achieving in ...
    (Date:8/3/2015)... Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) today ... 2015 Investor Conference Call and webcast at 4:30 p.m., Eastern ... will cover an update on Merrimack,s progress as well ... press release detailing the information to be discussed on ... August 10. Investors and the general public are invited ...
    (Date:8/3/2015)... SOUTH SAN FRANCISCO, Calif. , Aug. 3, ... therapeutics for the treatment of cancer, today announced ... team. Debanjan Ray , who ... and alliance management, has been promoted to senior ... to joining CytomX, Mr. Ray held positions as ...
    Breaking Medicine Technology:UpTick News Wire Radio Show Will Interview BioElectronics' CEO Andrew Whelan 2Merrimack Pharmaceuticals Announces Timing of Second Quarter 2015 Investor Conference Call 2CytomX Announces Management Team Promotions 2CytomX Announces Management Team Promotions 3
    ... 12 A,groundbreaking study developed by Breastcancer.org reports that ... information and messaging,around breast cancer. This study surveyed ... findings from this research revealed that nearly 30% of ... development was a symptom of,breast cancer, and more than ...
    ... VRUS ), a clinical stage pharmaceutical company committed ... financial results for the fiscal year ended September 30,2008. At ... cash,equivalents and short term investments. , ... Clevudine , ...
    Cached Medicine Technology:New Research Reveals Unforeseen Side Effect of the Breast Cancer Movement 2Pharmasset Reports Fiscal Year End 2008 Financial Results 2Pharmasset Reports Fiscal Year End 2008 Financial Results 3Pharmasset Reports Fiscal Year End 2008 Financial Results 4Pharmasset Reports Fiscal Year End 2008 Financial Results 5Pharmasset Reports Fiscal Year End 2008 Financial Results 6Pharmasset Reports Fiscal Year End 2008 Financial Results 7Pharmasset Reports Fiscal Year End 2008 Financial Results 8Pharmasset Reports Fiscal Year End 2008 Financial Results 9
    (Date:8/3/2015)... ... August 03, 2015 , ... ... amputation , AUGUST 3, 2015 – Since winning a South by Southwest® (SXSW®) ... Impossible – an organization whose mission is to develop technology for the sake ...
    (Date:8/3/2015)... ... August 03, 2015 , ... ... ® and Navigant Center for Healthcare Research and Policy Analysis show widespread support ... of respondents said they agreed or strongly agreed that the controversial law passed ...
    (Date:8/3/2015)... , ... August 03, 2015 , ... ... National Forest, to Ahjumawi Lava Springs, California’s northernmost and among its least visited ... untapped ground water aquifers, whose main outflow is at Ahjumawi Lava Springs, part ...
    (Date:8/3/2015)... ... 03, 2015 , ... A July 13 article from The Daily Mail titled ... Natural Painkiller That Can Last 'For Five Weeks'" discusses the use of stem ... study showed that harvesting stem cell-rich bone marrow from the hip, known as bone ...
    (Date:8/3/2015)... ... August 03, 2015 , ... Dignity Health named Dr. Norris ... Hospital Emergency Room – Gilbert, opening in August. The new facility is licensed ... the West Valley. , “Dr. Baldwin is an excellent leader and will ensure ...
    Breaking Medicine News(10 mins):Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 2Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 4Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3
    ... to Educate Health Care Stakeholders , ... The Virginia Business Coalition on Health (VBCH) announced ... reform efforts initiated by the Center for Medicare and ... "Never Events" - serious and costly preventable hospital errors. ...
    ... Consumer Watchdog said the health insurance industry,s support today ... it includes a requirement that every American buy insurance ... self-serving. The proposal amounts only to a customer delivery ... will not solve America,s health care problems and will ...
    ... BOULDER--The University Corporation for Atmospheric Research (UCAR), working ... organizations, is launching a project this month to ... Africa to help reduce outbreaks of meningitis. The ... vaccination programs more effectively for this deadly disease, ...
    ... Global Programs Required by New Legislation , ... United BioSource Corporation,s (UBC) Annette Stemhagen, DrPH, FISPE, and ... and Drug Safety Summit held in Washington, DC, on ... Director, CDER, FDA; Jane Axelrad, Associate Director for Policy, ...
    ... (NYSE:, LLY ) and the International Council of ... Chamber of Commerce Business Civic Leadership Center,(BCLC),s 9th annual ... Lilly and ICN were recognized for their groundbreaking work ... worldwide. A unique voting system landed Lilly and ...
    ... Nov. 19 Par Pharmaceutical,Companies, Inc. (NYSE: PRX ... distribution agreement with AstraZeneca in the U.S. to market budesonide,inhalation ... for the maintenance treatment of asthma. Par began,shipping 0.25 ... , Full-year US sales ...
    Cached Medicine News:Health News:Virginia Business Coalition on Health Issues Statement of Support for Hospital Improvement 2Health News:Virginia Business Coalition on Health Issues Statement of Support for Hospital Improvement 3Health News:Consumer Watchdog Comments on Health Insurer's Self-Serving Support of 'Individual Mandate' 2Health News:UCAR weather forecasts aim to reduce African meningitis epidemics 2Health News:UCAR weather forecasts aim to reduce African meningitis epidemics 3Health News:United BioSource Scientists, FDA, and Other Industry Leaders Present to Risk Management and Drug Safety Summit 2Health News:United BioSource Scientists, FDA, and Other Industry Leaders Present to Risk Management and Drug Safety Summit 3Health News:Lilly and International Council of Nurses Win Partnership Award From the U.S. Chamber of Commerce Business Civic Leadership Center 2Health News:Lilly and International Council of Nurses Win Partnership Award From the U.S. Chamber of Commerce Business Civic Leadership Center 3Health News:Par Pharmaceutical Begins Shipment of Budesonide Inhalation Suspension Immediately 2
    Tying forceps with 6.5 mm tying platform. Round handle with flats provide flexibility of round handle with the stability of a flat handle. Straight shafts. Overall length 3.9 inches....
    Curved shafts with 4 mm tying platform. Serrated handle with dull finish. Manufactured in titanium. Overall length 3.3 inches....
    Straight 6 mm platform. McPherson handle. Manufactured in titanium. Overall length 3.3 inches....
    Curved shafts and tips with 6.5 mm tying platform. Flat serrated handle with dull finish. Overall length 3.9 inches. Overall length 3.9 inches....
    Medicine Products: